Certificates of Analysis (COA) and Material Safety Data Sheets (MSDS) are available upon request to support EU institutional compliance
Figure 7: Time to the First Occurrence of the Composite of Cardiovascular Death*, Hospitalization for Heart Failure or Urgent Heart Failure Visit A) DAPA-HF Trial B) DELIVER Trial NOTE: An urgent heart failure visit was defined as an urgent, unplanned, assessment by a physician, e.g., in an Emergency Department, and requiring treatment for worsening heart failure (other than just an increase in oral diuretics)
A compounded semaglutide formulation may use different buffers, different preservatives (or no preservatives), different concentrations, and different vial or syringe configurations than brand-name products
Abbott BL, Colapietro AM, Barnes Y, Marini F, Andreeff M , Sorrentino BP